Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Other financing activities (2016 - 2017)

Lisata Therapeutics' Other financing activities history spans 4 years, with the latest figure at $231.0 for Q4 2017.

  • For Q4 2017, Other financing activities fell 99.53% year-over-year to $231.0; the TTM value through Sep 2018 reached $231.0, up 100.93%, while the annual FY2017 figure was -$74000.0, 101.85% down from the prior year.
  • Other financing activities reached $231.0 in Q4 2017 per LSTA's latest filing, down from $42314.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $49446.0 in Q4 2016 to a low of -$138127.0 in Q3 2016.